Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.

Maruoka Y, Nagaya T, Nakamura Y, Sato K, Ogata F, Okuyama S, Choyke PL, Kobayashi H.

Mol Pharm. 2017 Dec 4;14(12):4628-4635. doi: 10.1021/acs.molpharmaceut.7b00731. Epub 2017 Nov 22.

2.

Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.

Sato K, Watanabe R, Hanaoka H, Harada T, Nakajima T, Kim I, Paik CH, Choyke PL, Kobayashi H.

Mol Oncol. 2014 May;8(3):620-32. doi: 10.1016/j.molonc.2014.01.006. Epub 2014 Jan 22.

3.

Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).

Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Kobayashi H.

J Control Release. 2016 Jun 28;232:1-8. doi: 10.1016/j.jconrel.2016.04.003. Epub 2016 Apr 5.

4.

Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.

Railkar R, Krane LS, Li QQ, Sanford T, Siddiqui MR, Haines D, Vourganti S, Brancato SJ, Choyke PL, Kobayashi H, Agarwal PK.

Mol Cancer Ther. 2017 Oct;16(10):2201-2214. doi: 10.1158/1535-7163.MCT-16-0924. Epub 2017 Jun 15.

5.

Near Infrared Photoimmunotherapy with Combined Exposure of External and Interstitial Light Sources.

Maruoka Y, Nagaya T, Sato K, Ogata F, Okuyama S, Choyke PL, Kobayashi H.

Mol Pharm. 2018 Sep 4;15(9):3634-3641. doi: 10.1021/acs.molpharmaceut.8b00002. Epub 2018 Feb 21.

PMID:
29450993
6.

3D mesoscopic fluorescence tomography for imaging micro-distribution of antibody-photon absorber conjugates during near infrared photoimmunotherapy in vivo.

Tang Q, Nagaya T, Liu Y, Horng H, Lin J, Sato K, Kobayashi H, Chen Y.

J Control Release. 2018 Jun 10;279:171-180. doi: 10.1016/j.jconrel.2018.04.027. Epub 2018 Apr 16.

7.

Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer.

Ito K, Mitsunaga M, Nishimura T, Saruta M, Iwamoto T, Kobayashi H, Tajiri H.

Bioconjug Chem. 2017 May 17;28(5):1458-1469. doi: 10.1021/acs.bioconjchem.7b00144. Epub 2017 Apr 26.

PMID:
28402624
8.

Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.

Nagaya T, Sato K, Harada T, Nakamura Y, Choyke PL, Kobayashi H.

PLoS One. 2015 Aug 27;10(8):e0136829. doi: 10.1371/journal.pone.0136829. eCollection 2015.

9.

Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.

Aung W, Tsuji AB, Sugyo A, Takashima H, Yasunaga M, Matsumura Y, Higashi T.

World J Gastroenterol. 2018 Dec 28;24(48):5491-5504. doi: 10.3748/wjg.v24.i48.5491.

10.

Real-time monitoring of microdistribution of antibody-photon absorber conjugates during photoimmunotherapy in vivo.

Tang Q, Nagaya T, Liu Y, Lin J, Sato K, Kobayashi H, Chen Y.

J Control Release. 2017 Aug 28;260:154-163. doi: 10.1016/j.jconrel.2017.06.004. Epub 2017 Jun 8.

11.

Endoscopic near infrared photoimmunotherapy using a fiber optic diffuser for peritoneal dissemination of gastric cancer.

Nagaya T, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Kobayashi H.

Cancer Sci. 2018 Jun;109(6):1902-1908. doi: 10.1111/cas.13621. Epub 2018 May 29.

12.

Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate.

Nagaya T, Gorka AP, Nani RR, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Schnermann MJ, Kobayashi H.

Mol Cancer Ther. 2018 Mar;17(3):661-670. doi: 10.1158/1535-7163.MCT-17-0851. Epub 2017 Dec 13.

13.

Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer.

Nakamura Y, Ohler ZW, Householder D, Nagaya T, Sato K, Okuyama S, Ogata F, Daar D, Hoa T, Choyke PL, Kobayashi H.

Mol Cancer Ther. 2017 Feb;16(2):408-414. doi: 10.1158/1535-7163.MCT-16-0663. Epub 2016 Nov 15.

14.

Near infrared photoimmunotherapy with an anti-mesothelin antibody.

Nagaya T, Nakamura Y, Sato K, Zhang YF, Ni M, Choyke PL, Ho M, Kobayashi H.

Oncotarget. 2016 Apr 26;7(17):23361-9. doi: 10.18632/oncotarget.8025.

15.

Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer.

Harada T, Nakamura Y, Sato K, Nagaya T, Okuyama S, Ogata F, Choyke PL, Kobayashi H.

Oncotarget. 2016 Nov 29;7(48):79408-79416. doi: 10.18632/oncotarget.12710.

16.

Near infrared photoimmunotherapy in the treatment of disseminated peritoneal ovarian cancer.

Sato K, Hanaoka H, Watanabe R, Nakajima T, Choyke PL, Kobayashi H.

Mol Cancer Ther. 2015 Jan;14(1):141-50. doi: 10.1158/1535-7163.MCT-14-0658. Epub 2014 Nov 21.

17.

MR imaging biomarkers for evaluating therapeutic effects shortly after near infrared photoimmunotherapy.

Nakamura Y, Bernardo M, Nagaya T, Sato K, Harada T, Choyke PL, Kobayashi H.

Oncotarget. 2016 Mar 29;7(13):17254-64. doi: 10.18632/oncotarget.7357.

19.

Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes.

Kishimoto S, Oshima N, Yamamoto K, Munasinghe J, Ardenkjaer-Larsen JH, Mitchell JB, Choyke PL, Krishna MC.

Free Radic Biol Med. 2018 Feb 20;116:1-10. doi: 10.1016/j.freeradbiomed.2017.12.034. Epub 2017 Dec 29.

20.

Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.

Nakajima T, Sano K, Mitsunaga M, Choyke PL, Kobayashi H.

Cancer Res. 2012 Sep 15;72(18):4622-8. doi: 10.1158/0008-5472.CAN-12-1298. Epub 2012 Jul 16.

Supplemental Content

Support Center